This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: AOL, NKE, RIMM, UHS


AOL (AOL - Get Report) rated new Hold at ThinkEquity. $30 price target. Execution risk remains high, because of increased competition.

Biomarin (BMRN) rated new Buy at ThinkEquity. $44 price target. Company has a growing commercial franchise and a deep pipeline.

Buckeye Partners (BPL) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Low coverage ratio.

Celgene (CELG) upgraded at Argus from Hold to Buy, Argus Research said. $75 price target. Stock appears oversold, following a 20% decline.

Community Health (CYH) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Healthcare reform should help hospitals expand margins.

Caesars (CZR) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. $10 price target. Company has lost some top managers and growth is slowing in regional markets.

Enbridge Energy Partners (EEP) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $36 price target. Attractive growth outlook.

Lincare Holdings (LNCR) upgraded at Jefferies to Buy from Hold, Jefferies said. $38 price target. Risk-reward has improved.

Vail Resorts (MTN) upgraded at BofA/Merrill to Buy, Bank of America/Merrill Lynch said. $57 price target. Company is seeing higher prices and sales and using new summer initiatives.

Nike (NKE - Get Report) downgraded at Baird to Neutral. $85 price target. Stronger dollar and slower growth in China are hurting margins.

Nike downgraded at Sterne Agee to Neutral. Estimates also cut, given slower growth, especially in China.

Nike downgraded at DA Davidson to Neutral. $93 price target. Company faces growth headwinds and lowered guidance.

Saks (SKS - Get Report) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $12 price target. Company has mutli-year sales and margin growth drivers in place.

Swift (SWFT) downgraded at Citigroup to Neutral from Buy, Citigroup said. $10 price target. Macro will be a headwind to margin expansion.

Triumph Group (TGI) rated new Buy at Goldman. $73 price target. Company has multiple growth drivers, including the recent Vought acquisition.

Tenet Healthcare (THC) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call, relative to the group.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SKS $0.00 0.00%
AOL $39.44 0.00%
NKE $99.88 0.00%
UHS $118.10 0.00%
AAPL $123.25 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs